Fréquemment Questions posées
Nous sommes là pour vous ! Faites défiler pour voir les réponses aux diverses questions que nous recevons des fournisseurs de soins de santé.
What findings have you released/published?
The North American AED (Antiepileptic Drug) Pregnancy Registry has released and published information about many AEDs. Please click here for more information about the publications.
Can I access data on a specific drug that my patient is taking even if it hasn’t been released to the general public?
The Registry does not provide any information about certain drugs until they are reviewed and released by the Scientific Advisory Committee. To read more about the methods and release criteria, click here.
Who are your sponsors? Does being sponsored by pharmaceutical companies present a conflict of interest?
The North American AED (Antiepileptic Drug) Pregnancy Registry is sponsored by Abbvie, AdVanz, Greenwich Biosciences, Janssen, Pfizer, SK Life Sciences, Sunovian, Supernus, UCB, and Zogenix. The Registry is proud to be conducting this research within a non-biased academic setting and goes to great lengths to insure that its research follows scientifically rigorous guidelines in regards to release criteria, anonymity and confidentiality. (For more details, please see our methods section).
How many women enroll in the Registry per week?
Are you recruiting controls? How?
We are currently recruiting a control group for the Registry. We are asking Registry participants to ask their pregnant friends or family members (who are not taking AEDs) to enroll in our control group. For more information, please visit the control group page.
What does the Scientific Advisory Committee do?
What are your release criteria?
For information about our methods and release criteria, please click here.
Do you provide incentives for the study participant?
How do you ensure confidentiality?
What can you tell me about breastfeeding while taking AEDs?
Registre nord-américain des grossesses AED (médicaments antiépileptiques)
125, rue Nashua | Bureau 8438
Boston. Massachusetts 02114
SANS FRAIS : 1.888.233.2334
TÉLÉCOPIE : 617.643.0071